Atlas Trials

Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix

Clinical trial NCT02346227 · COMPLETED

Trial details

NCT number
NCT02346227
Sponsor
Jean-Pierre Van geertruyden
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Uterine Cervical DysplasiaPapillomavirus Infections
Start date
2015-01-01
Primary completion
2018-08-01
Enrollment
327

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.